A detailed history of Hartline Investment Corp transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Hartline Investment Corp holds 31,000 shares of PACB stock, worth $39,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,000
Holding current value
$39,370
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025

BUY
$1.14 - $2.1 $35,340 - $65,100
31,000 New
31,000 $36,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $286M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Hartline Investment Corp Portfolio

Follow Hartline Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hartline Investment Corp with notifications on news.